A group of tenacious students from the University of Leeds have joined a national effort to recruit more young stem cell donors and give patients with blood cancer and serious blood disorders a second ...

Cbio A/S today announced that it has received regulatory clearance to begin a first-in-human Phase I/IIa clinical trial of novoleucel, the company's ...

Dr Mark Burhenne, The Sleep Dentist, warns that common dental problems could indicate an imbalance in the oral microbiome, which may be linked to bowel cancer.

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

Radiopharm Theranostics maintains a "Hold" rating as its radiotherapeutic pipeline advances, with key data readouts expected in 2026. Click here to read.

The Citizens Life Sciences Conference 2026 March 11, 2026 2:15 PM EDTCompany ParticipantsDave Gancarz - Chief Business ...

The right balance between the seriousness of the disease and the excitement over advances in treatment makes this interactive, immersive experience memorable ...

Salspera has set out plans for a $91 million IPO to fund the phase 3 study of its bacteria-based cancer therapy. | Salspera has set out plans for a $91 million IPO to fund the phase 3 study of its ...

Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can "educate" the immune system to find and destroy disease-causing cells throughout ...

Researchers from the University of Liège and international collaborators have discovered an unexpected way to to stimulate the immune system against cancer: by subtly disrupting how tumour cells ...

The University of Iowa Health Care Holden Comprehensive Cancer Center has started treating its second patient — the second in the state — with a cellular therapy to fight synovial sarcoma, a rare and ...